Joshua Schechter - 31 May 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Aaron Perlitsh, Attorney-In-Fact for Joshua Schechter
Issuer symbol
LFCR
Transactions as of
31 May 2023
Net transactions value
$0
Form type
4
Filing time
01 Jun 2023, 18:37:19 UTC
Previous filing
11 May 2023
Next filing
05 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Options Exercise +9,474 +46% 29,931 31 May 2023 Direct F1, F2
holding LFCR Common Stock 2,000 31 May 2023 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Options Exercise $0 -9,474 -100% $0.000000* 0 31 May 2023 Common Stock 9,474 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 The restricted stock units vested on May 31, 2023.